Vertex Pharmaceuticals, Inc. (VRTX)
547.74
-0.31
(-0.06%)
USD |
NASDAQ |
Aug 24, 16:00
548.20
+0.46
(+0.08%)
After-Hours: 19:57
Vertex Pharmaceuticals 1 Year Total Returns (Daily) : 37.89% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 37.89% |
| August 20, 2026 | 37.00% |
| August 19, 2026 | 41.28% |
| August 18, 2026 | 35.48% |
| August 17, 2026 | 31.25% |
| August 14, 2026 | 29.58% |
| August 13, 2026 | 30.44% |
| August 12, 2026 | 35.58% |
| August 11, 2026 | 41.44% |
| August 10, 2026 | 42.93% |
| August 07, 2026 | 32.06% |
| August 06, 2026 | 25.51% |
| August 05, 2026 | 29.29% |
| August 04, 2026 | 1.36% |
| August 03, 2026 | 1.86% |
| July 31, 2026 | 4.43% |
| July 30, 2026 | 2.67% |
| July 29, 2026 | 3.19% |
| July 28, 2026 | 6.41% |
| July 27, 2026 | 1.99% |
| July 24, 2026 | 1.08% |
| July 23, 2026 | -0.81% |
| July 22, 2026 | 0.52% |
| July 21, 2026 | 5.13% |
| July 20, 2026 | 4.50% |
| Date | Value |
|---|---|
| July 17, 2026 | 4.83% |
| July 16, 2026 | 3.51% |
| July 15, 2026 | 2.77% |
| July 14, 2026 | 0.84% |
| July 13, 2026 | 2.43% |
| July 10, 2026 | 1.22% |
| July 09, 2026 | 3.66% |
| July 08, 2026 | 6.88% |
| July 07, 2026 | 13.68% |
| July 06, 2026 | 15.22% |
| July 02, 2026 | 15.54% |
| July 01, 2026 | 10.14% |
| June 30, 2026 | 11.57% |
| June 29, 2026 | 13.22% |
| June 26, 2026 | 10.81% |
| June 25, 2026 | 7.71% |
| June 24, 2026 | 5.54% |
| June 23, 2026 | 5.61% |
| June 22, 2026 | 5.88% |
| June 18, 2026 | 0.72% |
| June 17, 2026 | 3.85% |
| June 16, 2026 | 0.50% |
| June 15, 2026 | -1.10% |
| June 12, 2026 | -3.29% |
| June 11, 2026 | -1.64% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences, Inc. | 29.10% |
| Alnylam Pharmaceuticals, Inc. | -49.48% |
| Regeneron Pharmaceuticals, Inc. | 40.13% |
| Sionna Therapeutics, Inc. | -77.72% |
| Biogen, Inc. | 55.82% |